von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53 (original) (raw)

Association between Endothelial Progenitor Cells and von Willebrand Factor in Astrocytic Glioma

Priscilla Das

Life : international journal of health and life sciences, 2017

View PDFchevron_right

Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma

Peter Rheinstein

Glioma, 2018

View PDFchevron_right

Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients

Nikola Tanic

PLoS ONE, 2013

View PDFchevron_right

Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype

Sheryl Green

Cancer Genomics - Proteomics, 2019

View PDFchevron_right

Combined effects of two mutations in von Willebrand disease 2M phenotype

Debora Primrose

Research and Practice in Thrombosis and Haemostasis, 2017

View PDFchevron_right

Glioma Cell Biology

Aleksi Šedo

2014

View PDFchevron_right

Immunohistochemical expression of p53 and p21 in gliomas: a clinicopathological study

Jalal A Jalal

Zanco Journal of Medical Sciences, 2013

View PDFchevron_right

Prognostic genetic markers in malignant gliomas

Stefan Linsler

Romanian …

View PDFchevron_right

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses

Koichi Ichimura

Neuro-Oncology, 2010

View PDFchevron_right

Characterization of mutations identified in patients historically diagnosed with type 1 Von Willebrand disease

Nasher H Alyami

2014

View PDFchevron_right

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

Rosana Silva

Neuropathology and Applied Neurobiology, 2009

View PDFchevron_right

BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma

Mark Greenberg, Peter Dirks

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015

View PDFchevron_right

Accumulation of chromosomal changes in human glioma progression

Janusz Limon

Cancer Genetics and Cytogenetics, 1995

View PDFchevron_right

Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels

HERMINIO JOSE TAO

PLoS ONE, 2012

View PDFchevron_right

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Sek Kong

Nature, 2008

View PDFchevron_right

Concomitant p53 mutation and MYCN amplification in neuroblastoma

Reinaldo manhani

Medical and Pediatric Oncology, 1997

View PDFchevron_right

Analysis of Apoptosis and Cell Proliferation in Glioma Related to the Tumor Grade

WAWAN MULYAWAN

Advanced Science Letters, 2017

View PDFchevron_right

In Vivo Regulation of von Willebrand Factor Synthesis

philippe herve

Arteriosclerosis, Thrombosis, and Vascular Biology, 1999

View PDFchevron_right

Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells

Michael Berens

PLoS ONE, 2013

View PDFchevron_right

Clinical and molecular study of radiation-induced gliomas

Adéla Bubeníková

Scientific reports, 2024

View PDFchevron_right

Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas

Sven Wellmann

Acta Neuropathologica, 2005

View PDFchevron_right

Wilms’ Tumor Gene 1

Z. Vadas

Applied Immunohistochemistry & Molecular Morphology, 2012

View PDFchevron_right

Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes

Irene Slavc

Cancer Discovery, 2020

View PDFchevron_right

Glioblastoma: Therapeutic challenges, what lies ahead

Luciana Romão

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012

View PDFchevron_right

Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma

Simona Lamba

Cancer Research, 2007

View PDFchevron_right

Protein Markers Predict Survival in Glioma Patients

Jean-Eudes Dazard

Molecular & Cellular Proteomics, 2016

View PDFchevron_right

P53 at the Crossroads Between Cancer and Neurodegeneration

Cristina Lanni

Free Radical Biology and Medicine, 2012

View PDFchevron_right

MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma

Daniel Guillaume

Neuro-Oncology Advances

View PDFchevron_right

Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology

HERMINIO JOSE TAO

Neuro-Oncology, 2010

View PDFchevron_right

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance

Nicolas Weynants

Annals of Hematology, 2013

View PDFchevron_right

Review: On TRAIL for malignant glioma therapy?

Wijnand Helfrich

Neuropathology and Applied Neurobiology, 2010

View PDFchevron_right

Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma

Stefania Navone

Cancer Medicine, 2016

View PDFchevron_right

Wnt activation promotes neuronal differentiation of Glioblastoma

Natascia Tiso

Cell Death & Disease, 2013

View PDFchevron_right

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

Eirini Papadopoulou

BMC Cancer, 2019

View PDFchevron_right

Association between Functional EGF+61 Polymorphism and Glioma Risk

Sandra Costa

Clinical Cancer Research, 2007

View PDFchevron_right